Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis

Toshi A. Furukawa(Kyoto University), Georgia Salanti(University of Bern), Stefan Leucht(TUM Klinikum), Andrea Cipriani(Oxford Health NHS Foundation Trust), Philip J. Cowen(University of Oxford), Matthias Egger(University of Zurich)
The Lancet Psychiatry
June 7, 2019
Cited by 318


Related Papers